Skip to main content

Reporter April 10 2020

Study launched to test hydroxychloroquine as treatment for COVID-19

Apr. 8, 2020—  by Craig Boerner Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19. The ORCHID trial (Outcomes Related to...

Read more


VUMC team aids development of potential antiviral drug for COVID-19

Apr. 6, 2020—Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

Read more


Vanderbilt team develops COVID-19 predictive model for Tennessee

Apr. 6, 2020—A team including health economists, epidemiologists and a biostatistician at Vanderbilt University Medical Center and Vanderbilt University are amassing and processing data to develop a complex predictive model of the spread of COVID-19 within Tennessee, with region-specific projections, as well as a model of projected resource use during response to the pandemic.

Read more


Physicians, engineering students, families and friends construct DIY face shields

Apr. 2, 2020—As the number of COVID-19 infections continues to grow, Nashville resident Kobie Pretorius was searching for some way to provide meaningful help to others. And she realized her apprehension was spiking each morning as her husband went out the door for work.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more